The Mature B-Cell/Hairy Cell Panel by flow cytometry aids in the subtyping of mature B-cell neoplasms. Available as an add-on in conjunction with, or after, a Diagnostic/Prognostic Profile result has been reported by Genoptix or client. Markers tested by flow cytometry include CD5, CD11c, CD19, CD23, CD25, CD45, CD103 and FMC7.
Available in conjunction with, or after, a Diagnostic/Prognostic Profile result has been reported by Genoptix or client. Markers tested by flow cytometry include cLambda, cKappa, CD5, CD10, CD19, CD20, CD45 and CD103.
Cytogenetic abnormalities commonly associated with multiple myeloma (MM) are detected by fluorescence in situ hybridization (FISH). Probes for CKS1B-CDKN2C (1p32.3/1q21.3), 5q (5q-/-5/+5), 13q (13q-/-13), IGH (14q32.3), and TP53 (17p13.1) are included in the Myeloma Reflex FISH Profile (Enriched). If IGH positive, Genoptix will reflex to IGH/FGFR3 t(4;14), IGH/CCND1 t(11;14), IGH/MAF t(14;16) and IGH/MAFB t(14;20). Plasma cells are enriched from patient’s specimen using immunomagnetic enrichment technology with CD138 antibody.
Available as an add-on with an Intelligent Flow Profile. Markers tested by flow cytometry include CD5, CD11c, CD19, CD20, CD22, CD25, CD45, CD103, and FMC7.
Available as an add-on with an Intelligent Flow Profile. Markers tested by flow cytometry include cKappa, cLambda, CD5, CD19, CD10, CD11c, CD19, and CD20.
Genoptix, a NeoGenomics Company
2131 Faraday Ave
Carlsbad, CA 92008
Medical Director: Derek Lyle, MD
- NeoGenomics Completes Acquisition of Genoptix, Inc.December 10, 2018 - 9:00 am
- NeoGenomics Signs Definitive Agreement to Acquire GenoptixOctober 23, 2018 - 9:00 am
- Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna® (nilotinib)September 4, 2018 - 8:30 am
HOURS OF OPERATION
Our lab is open six days a week:
5:00am to 6:00pm PT Mon-Fri
7:00am to 3:30pm PT Saturday
For after-hours assistance, your call
will be connected with an on-duty
Client Services Representative.